Skip to main content

Table 3 Prescription and high-dose rates of most frequently prescribed psychotropic medications (n = 806)

From: Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study

Prescribed medications

n (%)

High-dose (TDD/MDD > 1)

Antipsychotics

 Quetiapine

 Olanzapine

 Aripiprazole

 Clozapine

 Lurasidone

 Risperidone

 Paliperidone

 Zuclopenthixol

 Other

321

120 (37.4)

83 (25.9); (LAI n = 1)

38 (11.8); (LAI n = 6)

22 (6.9)

15 (4.7)

8 (2.5); (LAI n = 1)

7 (2.2); (LAI n = 6)

4 (1.3); (LAI n = 4)

24 (7.5); (LAI n = 1)

8 (2.5)

1

4

2

nil

nil

nil

1

nil

nil

Antidepressants

 Venlafaxine

 Mirtazapine

 Sertraline

 Escitalopram

 Fluoxetine

 Desvenlafaxine

 Duloxetine

 Citalopram

 Nortriptyline

 Other

247

39 (15.8)

36 (14.6)

30 (12.2)

26 (10.5)

26 (10.5)

25 (10.1)

22 (8.9)

9 (3.7)

5 (2.0)

29 (11.7)

25 (10.1)

nil

6

1

7

3

2

3

nil

1

2

Benzodiazepines

 Diazepam

 Lorazepam

 Clonazepam

 Temazepam

 Other

62

43 (69.4)

6 (9.7)

4 (6.5)

4 (6.5)

5 (8.1)

nil

Mood stabilisers

 Lithium

 Lamotrigine

 Valproate

 Topiramate

 Other

176

65 (36.9)

64 (36.4)

36 (20.5)

7 (4)

4 (2.3)

N/A*

  1. LAI = long-acting injectable antipsychotic; TDD = total daily dose; MDD = maximum daily dose
  2. *High dose information not available for mood stabilisers